NCT05076019View on ClinicalTrials.gov

Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement

NARecruitingINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Postoperative Atrial Fibrillation
Interventions
DRUG

Atorvastatin 80mg

Dosage: 80 mg Form: Tablets Frequency: 1 tabl. per day. Duration: From 7 to 14 days prior to surgery until 30 days postoperative

DRUG

Placebo

Form: Tablets Frequency: 1 tabl. per day. Duration: From 7 to 14 days prior to surgery until 30 days postoperative

Trial Locations (1)

5000

RECRUITING

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense Patient Data Explorative Network

OTHER

collaborator

GCP-unit at Odense University Hospital

UNKNOWN

lead

Odense University Hospital

OTHER